ACP-204 for Lewy Body Dementia Psychosis
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
- Age
- 55 – 84
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 180 (estimated)
- Sponsor
- ACADIA Pharmaceuticals Inc. · Industry
This trial is looking for people aged 55 to 85 with Lewy Body Dementia Psychosis. Participants will take part in a 6-week study to find out if the drug ACP-204 is effective and safe.
You may be able to join if
- I am between 55 and 85 years old.
- I can provide written consent or have a legal representative do so.
- I have been diagnosed with Parkinson's disease with dementia or dementia with Lewy bodies.
- I have psychosis in relation to my dementia.
You may not be able to join if
- I am in hospice care or bedridden.
- I have psychotic symptoms due to substance abuse or other psychiatric conditions.
- I am actively suicidal.
- I have a serious ongoing medical condition that affects my ability to participate.
- I have other significant brain issues affecting my dementia.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityMulticenter, randomized, 6-week, double-blind, placebo-controlled, parallel-group, Phase 2 study in subjects with LBDP.
Loading trial locations…